GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)

/PRNewswire/ -- GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA) has approved ALYGLO (immune globulin intravenous,...

Related Keywords

Canada ,United States ,South Korea ,Selena Perez ,Sohee Kim ,Yelin Jun ,Xia Fxia ,Seunghyun Baek ,Cation Exchange Chromatography ,Drug Administration ,Gc Biopharma Corp ,Gc Biopharma United States Inc ,Allergy Associates Of The Palm Beaches ,Green Cross Corporation ,Allergy Immunologist ,Allergy Associates ,Palm Beaches ,Cardiovascular Medicine ,Eun Chul Huh ,Humoral Immunodeficiency ,Increased Serum Viscosity ,Meningitis Syndrome ,Related Acute Lung Injury ,Infectious Agents ,Laboratory Tests ,United States Contact ,Green Cross ,Gc Biopharma ,